Yesterday's News, May 22, 2013

8:00p
FDA Recommends Running Phase 2b Trial of Proellex(R)-V in the Treatment of Severe Menstrual Bleeding Associated With Uterine Fibroids   (GlobeNewswire)

May 10, 2013

9:25a
Repros Therapeutics Inc.(R) Reports First Quarter 2013 Financial Results   (GlobeNewswire)

May 2, 2013

12:59p
Repros Reports Second Pivotal Androxal(R) Study Fully Enrolled Ahead of Schedule   (GlobeNewswire)

April 29, 2013

12:00p
Repros' Proellex(R) in Breast Cancer Phase 2 Study in Collaboration With Northwestern University   (GlobeNewswire)
11:33a
Repros to Present at the Bank of America Merrill Lynch 2013 Health Care Conference   (GlobeNewswire)

April 12, 2013

4:40p
Repros Gets Additional Patents - Analyst Blog   (Zacks.com)

April 11, 2013

9:15a
News Briefing for Health Care Sector Companies: Embark Holdings, Vitamin Shoppe, MusclePharm, Repros Therapeutics, Unilife and Pfizer   (PR NewsWire)

April 10, 2013

12:22p
Repros Reports Issuance of Two Additional U.S. Androxal(R) Patents   (GlobeNewswire)

April 4, 2013

4:43p
Positive Data on Repros' Androxal - Analyst Blog   (Zacks.com)

April 1, 2013

10:09a
S&P 500 Climbs to New Record and EBay to Handle $110 Billion of Marketplace Volume in 2015   (PR NewsWire)
8:00a
Morning Research on Amgen, Affymax, Vertex Pharma, Questcor Pharma, and Repros Therapeutics   (PR NewsWire)

March 28, 2013

4:51p
UPDATE 5: Thursday movers: Apple falls 17% in first quarter   (MarketWatch)
2:08p
UPDATE 4: Thursday movers: BlackBerry up, Apple stuck in red   (MarketWatch)
12:27p
UPDATE 3: Thursday movers: BlackBerry gains as Apple drops   (MarketWatch)
10:39a
UPDATE 2: Thursday movers: BlackBerry up on surprise profit   (MarketWatch)
10:36a
UPDATE 1: Thursday movers: BlackBerry up on surprise profit   (MarketWatch)
8:34a
Thursday's movers: BlackBerry, Accenture   (MarketWatch)

March 27, 2013

8:00p
Repros Reports Both Primary Endpoints Successfully Met in First Pivotal Study of Androxal(R)   (GlobeNewswire)

March 25, 2013

10:04a
American Urological Association (AUA) Accepts Androxal(R) Versus Topical Gel Comparative Study for Podium Presentation at Annual Meeting   (GlobeNewswire)

March 18, 2013

9:25a
Repros Therapeutics Inc.(R) Reports Fourth Quarter and Year End 2012 Financial Results   (GlobeNewswire)

February 28, 2013

9:25a
FDA Grants Repros an End of Phase 2 Meeting in Late May to Discuss Proellex(R)-V Phase 3 Study Design   (GlobeNewswire)
Go to All Current & Historical News